4//SEC Filing
MURPHY ANDREW J 4
Accession 0001796226-25-000005
CIK 0000872589other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:06 PM ET
Size
10.2 KB
Accession
0001796226-25-000005
Insider Transaction Report
Form 4
MURPHY ANDREW J
EVP Research
Transactions
- Tax Payment
Common Stock
2025-10-29$648.82/sh−32,490$21,080,162→ 51,584 total - Gift
Common Stock
2025-10-30−1,538→ 50,046 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-29−35,000→ 0 totalExercise: $555.67Exp: 2025-12-16→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2025-10-29$555.67/sh+35,000$19,448,450→ 84,074 total
Holdings
- 4,370(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The stock option award vested in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001796226
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:06 PM ET
- Size
- 10.2 KB